4061 Denka
- 2176.0
- +22.0+1.02%
Denka News
Denka: Regarding the decision of the United States federal appeals court regarding the injunction petition raised by our subsidiary in the United States.
Denka: Independent Officer Notification Form
Denka: Announcement of application of new regulations by the United States Environmental Protection Agency to chloroprene rubber manufacturing facilities in the United States
Denka: Notice Concerning the Recording of Gains (Extraordinary Profit) from the Sale of Investment Securities
Denka: Notice regarding changes in officers, etc.
Denka: Notice regarding cancellation of norovirus vaccine development and recording of extraordinary losses at overseas consolidated subsidiaries
Denka: [Delayed]Corporate Governance Report
Denka: [Delayed]Corporate Governance Report
Denka: Partial voluntary return of executive remuneration due to fatal accidents that occurred at the Aomi Plant and inappropriate acts such as third party certification in resin products
Denka: Publication of the investigation report by the External Investigation Committee and the Company Group's countermeasures regarding improper acts such as third-party certification in resin products of our company and affiliated companies applying the
Denka: (Progress of Disclosure Matters) Notice of Establishment of a Joint Venture (Subsidiary) to Conduct Acetylene Black Manufacturing and Sales Business and Investment Decision for Production Plant Construction
Denka: Notice of establishment of a joint venture (subsidiary) to manufacture and sell acetylene black and decision to invest in construction of a production plant
Denka: [Delayed]Corporate Governance Report
Denka: [Delayed]Corporate Governance Report
Denka: Notice Concerning Decisions on Matters Relating to Stock Acquisition under the Stock Remuneration System
Denka: Articles of Incorporation 2023/03/01
Denka: Improper acts such as third party certification in resin products of our company and affiliated companies applying the equity method, and the establishment of an external investigation committee by external experts
Denka: Independent Officer Notification Form
Denka: Legal ex post facto disclosure documents (company split) (TD Cement Co., Ltd.)
Denka: Investment to increase manufacturing capacity for cancer treatment virus G47delta preparations has been decided - Responding to future increases in demand through a strategic investment of approximately 12 billion yen
Analysis
Price Target
No Data
